Axonics, Inc. (NASDAQ:AXNX) Q2 2022 Earnings Conference Call August 1, 2022 4:30 PM ET

Company Participants

Neil Bhalodkar - Investor Relations

Raymond Cohen - Chief Executive Officer

Dan Dearen - President & Chief Financial Officer

Conference Call Participants

Travis Steed - Bank of America Securities

Adam Maeder - Piper Sandler

Cecilia Furlong - Morgan Stanley

Lawrence Biegelsen - Wells Fargo Securities

Mike Polark - Wolfe Research

Mike Matson - Needham & Company

Operator

Good day and thank you for standing by. Welcome to the Axonics Q2 2022 Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded.

And I would now like to hand the conference over to your host today Mr. Neil Bhalodkar. Mr. Bhalodkar, please go ahead.

Neil Bhalodkar

Thank you. Good afternoon and thank you for joining Axonics' second quarter 2022 results and update call. Presenting on today's call are Raymond Cohen, Chief Executive Officer; and Dan Dearen, President and Chief Financial Officer.

Before we begin, I'd like to remind listeners that statements made on this conference call that relate to future plans, events, prospects or performance are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995.

While these forward-looking statements are based on management's current expectations and beliefs, these statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause results to differ materially from the expectations expressed on this conference call.

These risks and uncertainties are disclosed in more detail in Axonics' filings with the Securities and Exchange Commission, all of which are available online at www.sec.gov. Listeners are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date, August 1, 2022.

Except as required by law, Axonics undertakes no obligation to update or revise any forward-looking statements to reflect new information, circumstances or unanticipated events that may arise.

I would now like to turn the call over to Ray.

Raymond Cohen

Excellent. Thanks Neil. I would like to welcome everyone joining this afternoon's call. We're very proud of our second quarter 2022 financial results. Axonics generated total revenue of $69 million in the second quarter of 2022, which represents growth of 50% year-over-year. This record revenue result reflects growing demand for our best-in-class incontinence solutions.